According to FutureWise analysis the market for recombinant cell culture supplements in 2023 is US$ 0.52 billion, and is expected to reach US$ 0.84 billion by 2031 at a CAGR of 6.2%.
Cell culture offers essential information pertaining the physiology and biochemistry of cells, which is difficult to comprehend on in vivo conditions. Furthermore, thee methods aid in analysing the effects of drugs on factors like culture conditions, growth rate and population density. Cell culture supplements are important in aiding mammalian cells in producing proteins, which are the crucial ingredients of biologic drugs. Media supplement help in customizing and regulating the cell growth conditions and prolonged maintenance of healthy cells along with improvements in the virality and growth of cells. Many crucial factors are considered during cell supplement addition that includes the state of addition like solution, powder or emulsion supplement components. Recombinant proteins are comprehensively used as cell culture supplements for boosting productivity, growth and consistency. The serum-free cell line are developed with the use of these recombinant proteins.
Rising demand in projects related to cell cultures is one of the major factors responsible for the growth of the market. Furthermore, increased use of animal-free supplements for manufacturing biopharmaceuticals, stem cells and vaccines are some other factors contributing to the recombinant cell culture supplements market growth. Moreover, growing investment in research and development activities in the life science sector shall bolster the proliferation of the market.